Gabriel Figueroa-Parra, MD, MSc

Assistant Professor of Rheumatology @uanl | LUMEN Research Collaborator @mayoclinic | Tweets are my own / 🐘☕🩺📖 / Left-handed.

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

Scientific Oath 🙋🏻‍♂️
I promise to work for a better world, where science and technology are used in socially responsible ways. I will not use my education for any purpose intended to harm human beings or the environment... 1/2

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

@JoseMeadeMD @MayoPCCM Felicidades José!

[Mithu Maheswaranathan, MD @MithuRheum]

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋

Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance

➠ Read the Full Guideline: https://t.co/jNwvKWbFpE

#RheumX #RheumTwitter #Rheum @RheumNow

[ACR_Journals @ACR_Journals]

Now published: The 2025 ACR Guideline for the Treatment of Systemic Lupus Erythematosus

📄 Read the paper: https://t.co/56eOK86lmn

ℹ️ See additional content and resources on this guideline at https://t.co/PVEyOkY14w

[American College of Rheumatology @ACRheum]

NEW! The ACR just released an updated clinical practice guideline for #SLE! Key recommendations include universal hydroxychloroquine use, lower steroid exposure, & earlier immunosuppressive therapy. Patient-centered care is central. READ MORE → https://t.co/wRUuS5p2HG

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

Great summary!

[American College of Rheumatology @ACRheum]

NEW ACR clinical practice guideline provides recommendations regarding treatment of systemic lupus erythematosus (SLE) in both adults and children. FULL GUIDELINE → https://t.co/XKNZBDRKOm #SLE #lupus

[Jaime Flores-Gouyonnet, MD @JaimeFG_MD]

Honored to present our work at #ACR25:
“Differential Risk of Inpatient Admissions Among SLE Subgroups: A Population-Based Analysis.”
Grateful to my mentor @AliDuarteMD and the LUMEN team for their outstanding collaboration and guidance.
#Rheumatology #Lupus #LupusResearch

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

Happy with my friend Mario Bautista, receiving the "Griffing-Nelson Award" during the Hench Society event for his outstanding abstract!
All invited to the presentation #today at S102 (SLE abstracts) #ACR2025

[American College of Rheumatology @ACRheum]

Congratulations to Eric L. Matteson, MD, MPH, recipient of the 2025 Presidential Gold Medal Award! @MayoClinic #ACR25

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

🚨🚨🚨

[American College of Rheumatology @ACRheum]

NEW #SLE clinical practice guideline to be unveiled at #ACR25! ✨

Don’t miss this important session—2025 American College of Rheumatology Guideline for the Treatment of Systemic Lupus Erythematosus, Saturday, Oct. 26, 9:00-10:30 AM CT. DETAILS → https://t.co/fayutXpTH0

COMING SOON: Full guideline manuscript. Stay tuned 👀 → https://t.co/vVRcKYssrb

[Circulation @CircAHA]

YAP1-CCN2 signaling enables proproliferative communication between microvascular ECs and vascular SMCs in patients with antiphospholipid syndrome (APS) vasculopathy. Inhibiting the pathway could lead to a targeted treatment approach @RayZuoMD @DrGabrielFP https://t.co/Ov4hcWDyjD

[American College of Rheumatology @ACRheum]

#ACR25 abstracts now online! 🎉 Browse over 3,100 abstracts representing the highest-impact research in the field of #rheum. NOTE: Information that goes beyond that contained in the abstract is under media embargo until Oct. 25 at 10:00 AM CT. View 👀 → https://t.co/o0fpZCHZLC

[American College of Rheumatology @ACRheum]

NEW EPISODE! Alain Sanchez-Rodriguez, MD, joins the podcast to discuss delays in #lupus diagnosis & care based on findings from the Lupus Midwest Network (LUMEN)🎙️LISTEN NOW → https://t.co/8UZWFRmHJJ @ACR_Journals

[Alain Sanchez, MD @lain_sanchez]

Thanks so much for this opportunity!!

https://t.co/9YxL9bodhT

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

📢📢 Oficialmente, las guías 2024 del ACR para nefritis lúpica disponibles en extenso!!

[ACR_Journals @ACR_Journals]

Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis

See ACR guideline page for resources - https://t.co/zhvkPxCTcr

DOI link - https://t.co/Hllq83J7Kc

Download the article - https://t.co/uAJ7JaO7pz

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

I wasn't expecting this! 😮
Shout-out to @MariaCuellarMD, @AliDuarteMD, and all the team!

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

📢📢📢Check out the new 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis!!!
Now available online: https://t.co/gzYGYSfj02

[Manuel Ugarte-Gil @mugartegil]

🚨🆕paper: #hypertension predicts #global and #renal #damage in #SLE #lupus data from the #AlmenaraLupusCohort @cientifica_sur @EsSaludPeru @PanlarLeague published in @SageHealthInfo https://t.co/sJEtAT1cWB

[Jaime Flores-Gouyonnet, MD @JaimeFG_MD]

🚨New Research Alert 🚨

Excited to share our latest study in @TheLancetRheum

We analyzed the accuracy, quality, and safety of Large Language Models —ChatGPT-4, Claude 3: Opus and Gemini Advanced— in rheumatology board-like questions.

Read more:

https://t.co/sqZk6ODPqW

[Jason S Knight @jasonsknight]

Antiphospholipid Antibodies Linked to Increased Risk for Diffuse Alveolar Hemorrhage in SLE https://t.co/Gklxo72knS

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

@lain_sanchez @JoseMeadeMD @marianagt95 @MariaCuellarMD @CDCChronic @MayoGradSchool @RochesterEpi

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

🧵 1/6 New research alert! 🚨 Our most recent LUMEN (💡) paper explores the utility of the 2019 EULAR/ACR SLE classification criteria in predicting mortality and hospitalization in patients with SLE. #LupusResearch #SLE. https://t.co/CIS4f0z8fL

[Gabriel Figueroa-Parra, MD, MSc @DrGabrielFP]

This study is derived from my master’s degree thesis. I would like to thank my mentors @AliDuarteMD, @CrowsonCindy, and my TAC: Matthew J. Koster, MD, @LadanZand, and @mugartegil.
Also, thanks to all coauthors and funding sources that made this project possible.